Table 6.
Univariable and multivariable analyses of time to CSM
| Univariable | Multivariable | |||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| All patients | ||||
| Non-BCG | 1.0 | 1.0 | ||
| BCG | 0.40 (0.21–0.77) | 0.006 | 0.58 (0.29–1.16) | NS |
| Ex. CIS | ||||
| Non-BCG | 1.0 | 1.0 | ||
| BCG | 0.45 (0.24–0.86) | 0.016 | 0.78 (0.39–1.55) | NS |
| Ex CIS and concomitant CIS | ||||
| Non-BCG | 1.0 | 1.0 | ||
| BCG | 0.46 (0.22–0.94) | 0.034 | 0.75 (0.35–1.62) | NS |
Multivariable analysis after stepwise selection: age and stage
BCG Bacillus Calmette–Guérin, CI confidence interval, CSM cancer-specific mortality, HR hazard ratio, CIS cancer in situ, NS non-significant